Advanced Proteome Therapeutics Corporation
APTCF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3,518 | $88,778 | $22,158 | $19,010 |
| - Cash | $544 | $822 | $2 | $132 |
| + Debt | $332 | $325 | $297 | $194 |
| Enterprise Value | $3,305 | $88,281 | $22,452 | $19,072 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$5 | -$3 | -$3 | -$4 |
| % Margin | – | – | – | – |
| EBITDA | -$937 | -$648 | -$567 | -$890 |
| % Margin | – | – | – | – |
| Net Income | $760 | -$1,835 | -$451 | -$333 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.019 | -0.059 | -0.02 | -0.019 |
| % Growth | 132.7% | -190.6% | -5.2% | – |
| Operating Cash Flow | -$694 | -$545 | -$467 | -$686 |
| Capital Expenditures | -$14 | -$2 | $0 | -$1 |
| Free Cash Flow | -$707 | -$547 | -$467 | -$687 |